These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 33039679)

  • 1. Genetic manipulation of phages for therapy using BRED.
    Payaslian F; Gradaschi V; Piuri M
    Curr Opin Biotechnol; 2021 Apr; 68():8-14. PubMed ID: 33039679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic Manipulation of Lytic Bacteriophages with BRED: Bacteriophage Recombineering of Electroporated DNA.
    Marinelli LJ; Piuri M; Hatfull GF
    Methods Mol Biol; 2019; 1898():69-80. PubMed ID: 30570724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacteriophage genome engineering for phage therapy to combat bacterial antimicrobial resistance as an alternative to antibiotics.
    Usman SS; Uba AI; Christina E
    Mol Biol Rep; 2023 Aug; 50(8):7055-7067. PubMed ID: 37392288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction of a genetically modified T7Select phage system to express the antimicrobial peptide 1018.
    Lemon DJ; Kay MK; Titus JK; Ford AA; Chen W; Hamlin NJ; Hwang YY
    J Microbiol; 2019 Jun; 57(6):532-538. PubMed ID: 31054139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engineered Bacteriophage Therapeutics: Rationale, Challenges and Future.
    Łobocka M; Dąbrowska K; Górski A
    BioDrugs; 2021 May; 35(3):255-280. PubMed ID: 33881767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineering therapeutic phages for enhanced antibacterial efficacy.
    Meile S; Du J; Dunne M; Kilcher S; Loessner MJ
    Curr Opin Virol; 2022 Feb; 52():182-191. PubMed ID: 34952266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Covalent Modifications of the Bacteriophage Genome Confer a Degree of Resistance to Bacterial CRISPR Systems.
    Liu Y; Dai L; Dong J; Chen C; Zhu J; Rao VB; Tao P
    J Virol; 2020 Nov; 94(23):. PubMed ID: 32938767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phages amid antimicrobial resistance.
    Mohan Raj JR; Karunasagar I
    Crit Rev Microbiol; 2019; 45(5-6):701-711. PubMed ID: 31775552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of single and combined use of bacteriophages and antibiotics to inactivate Escherichia coli.
    Valério N; Oliveira C; Jesus V; Branco T; Pereira C; Moreirinha C; Almeida A
    Virus Res; 2017 Aug; 240():8-17. PubMed ID: 28746884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implication of a gene deletion on a Salmonella Enteritidis phage growth parameters.
    Milho C; Sillankorva S
    Virus Res; 2022 Jan; 308():198654. PubMed ID: 34902446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BRED: a simple and powerful tool for constructing mutant and recombinant bacteriophage genomes.
    Marinelli LJ; Piuri M; Swigonová Z; Balachandran A; Oldfield LM; van Kessel JC; Hatfull GF
    PLoS One; 2008; 3(12):e3957. PubMed ID: 19088849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modified phages: novel antimicrobial agents to combat infectious diseases.
    Moradpour Z; Ghasemian A
    Biotechnol Adv; 2011; 29(6):732-8. PubMed ID: 21689739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic Biology to Engineer Bacteriophage Genomes.
    Rita Costa A; Milho C; Azeredo J; Pires DP
    Methods Mol Biol; 2018; 1693():285-300. PubMed ID: 29119447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibacterial application of engineered bacteriophage nanomedicines: antibody-targeted, chloramphenicol prodrug loaded bacteriophages for inhibiting the growth of Staphylococcus aureus bacteria.
    Vaks L; Benhar I
    Methods Mol Biol; 2011; 726():187-206. PubMed ID: 21424451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phage Therapy: Going Temperate?
    Monteiro R; Pires DP; Costa AR; Azeredo J
    Trends Microbiol; 2019 Apr; 27(4):368-378. PubMed ID: 30466900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysing Parallel Strategies to Alter the Host Specificity of Bacteriophage T7.
    Avramucz Á; Møller-Olsen C; Grigonyte AM; Paramalingam Y; Millard A; Sagona AP; Fehér T
    Biology (Basel); 2021 Jun; 10(6):. PubMed ID: 34202963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutant and Recombinant Phages Selected from
    Peters TL; Song Y; Bryan DW; Hudson LK; Denes TG
    Appl Environ Microbiol; 2020 Oct; 86(22):. PubMed ID: 32887717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ameliorating the antimicrobial resistance crisis: phage therapy.
    Saha D; Mukherjee R
    IUBMB Life; 2019 Jul; 71(7):781-790. PubMed ID: 30674079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transfer of antibiotic-resistance genes via phage-related mobile elements.
    Brown-Jaque M; Calero-Cáceres W; Muniesa M
    Plasmid; 2015 May; 79():1-7. PubMed ID: 25597519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthetic Biology to Engineer Bacteriophage Genomes.
    Costa AR; Azeredo J; Pires DP
    Methods Mol Biol; 2024; 2734():261-277. PubMed ID: 38066375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.